Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-036056

Global Blood Therapeutics, Inc. · GBT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin P Starr
10% Owner
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 16, 2016S108,955$16.0006D82,544D
Common StockF2holding———7,475,191ISee Footnote
Common StockF3holding———1,285,713ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses